Harrow Ebitda from 2010 to 2024
| HROW Stock | USD 38.08 1.94 4.85% |
EBITDA | First Reported 2006-06-30 | Previous Quarter 2.9 M | Current Value 4.7 M | Quarterly Volatility 4.3 M |
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 87.2 M or Selling And Marketing Expenses of 37.7 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
Harrow | Ebitda |
Latest Harrow Health's Ebitda Growth Pattern
Below is the plot of the Ebitda of Harrow Health over the last few years. It is Harrow Health's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
| Ebitda | 10 Years Trend |
|
Ebitda |
| Timeline |
Harrow Ebitda Regression Statistics
| Arithmetic Mean | (3,733,733) | |
| Coefficient Of Variation | (211.57) | |
| Mean Deviation | 6,229,575 | |
| Median | (3,203,000) | |
| Standard Deviation | 7,899,279 | |
| Sample Variance | 62.4T | |
| Range | 25.1M | |
| R-Value | 0.45 | |
| Mean Square Error | 53.7T | |
| R-Squared | 0.20 | |
| Significance | 0.09 | |
| Slope | 792,896 | |
| Total Sum of Squares | 873.6T |
Harrow Ebitda History
About Harrow Health Financial Statements
Harrow Health investors use historical fundamental indicators, such as Harrow Health's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harrow Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBITDA | 9.7 M | 10.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.